As of 4:02pm ET
| +0.12 / +0.28%|
The 6 analysts offering 12-month price forecasts for WuXi PharmaTech (Cayman) Inc have a median target of 46.00, with a high estimate of 51.00 and a low estimate of 42.00. The median estimate represents a +8.70% increase from the last price of 42.32.
The current consensus among 8 polled investment analysts is to Hold stock in WuXi PharmaTech (Cayman) Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.